341 related articles for article (PubMed ID: 26586486)
1. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.
Needham M; Mastaglia FL
Neurotherapeutics; 2016 Jan; 13(1):132-46. PubMed ID: 26586486
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
Tournadre A
Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
[TBL] [Abstract][Full Text] [Related]
4. Current treatment of the inflammatory myopathies.
Dalakas MC
Curr Opin Rheumatol; 1994 Nov; 6(6):595-601. PubMed ID: 7865379
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
Haq SA; Tournadre A
Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
Quick A; Tandan R
Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
[TBL] [Abstract][Full Text] [Related]
7. Targeted immunotherapy trials for idiopathic inflammatory myopathies.
Stübgen JP
J Neurol; 2013 Feb; 260(2):368-85. PubMed ID: 22752063
[TBL] [Abstract][Full Text] [Related]
8. Treatment of idiopathic inflammatory myopathies.
Amato AA; Griggs RC
Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
[TBL] [Abstract][Full Text] [Related]
9. Clinical Evaluation and Management of Inflammatory Myopathies.
Chhibber S; Amato AA
Semin Neurol; 2015 Aug; 35(4):347-59. PubMed ID: 26502759
[TBL] [Abstract][Full Text] [Related]
10. Biologic therapy in the idiopathic inflammatory myopathies.
Khoo T; Limaye V
Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
[TBL] [Abstract][Full Text] [Related]
11. [Biological therapy in idiopathic inflammatory myopathies].
Bodoki L; Nagy-Vincze M; Griger Z; Péter A; András C; Dankó K
Orv Hetil; 2014 Jan; 155(1):3-10. PubMed ID: 24379090
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory myopathies and lymphoma.
Stübgen JP
J Neurol Sci; 2016 Oct; 369():377-389. PubMed ID: 27653927
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.
Dalakas MC
Neuromuscul Disord; 2006 Apr; 16(4):223-36. PubMed ID: 16542836
[No Abstract] [Full Text] [Related]
14. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis.
Tidball JG; Wehling-Henricks M
Curr Opin Rheumatol; 2005 Nov; 17(6):707-13. PubMed ID: 16224247
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
Megens-de Letter MA; Visser LH; van Doorn PA; Savelkoul HF
Eur Cytokine Netw; 1999 Dec; 10(4):471-8. PubMed ID: 10586113
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and treatment of inflammatory myopathies.
Amato AA; Barohn RJ
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1060-8. PubMed ID: 19762898
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.
Pagnini I; Vitale A; Selmi C; Cimaz R; Cantarini L
Clin Rev Allergy Immunol; 2017 Feb; 52(1):34-44. PubMed ID: 26429707
[TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
19. Therapy for myositis.
Oddis CV
Curr Opin Rheumatol; 1993 Nov; 5(6):742-8. PubMed ID: 8117536
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
Moran EM; Mastaglia FL
Clin Exp Immunol; 2014 Dec; 178(3):405-15. PubMed ID: 25171057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
